Document:

<PAGE>   1
                                  EXHIBIT 10.24

                       SEVENTH AMENDMENT TO LOAN DOCUMENTS

         THIS SEVENTH AMENDMENT TO LOAN DOCUMENTS (THE "AMENDMENT"), is entered
into on the Closing Date, as defined in paragraph 30 below, among PNC BANK,
NATIONAL ASSOCIATION, a national banking association, having an address at 2
Tower Center, East Brunswick, New Jersey 08816 (the "Lender"); COACTIVE
MARKETING GROUP, INC., (formerly known as Inmark Enterprises, Inc.
("Enterprises")), a Delaware corporation ("CoActive"); U.S. CONCEPTS, INC., a
Delaware Corporation ("USC"); INMARK SERVICES, INC., a Delaware corporation
("Services"), and OPTIMUM GROUP, INC., an Ohio corporation (formerly, OG
Acquisition Corp.) ("New OGI" and together with Services and USC, the
"Borrower"). CoActive, USC, Services, and New OGI are collectively referred to
herein as the "Inmark Group".

                                   WITNESSETH:

         WHEREAS, Lender is the holder of a certain Term Note dated March 31,
1998 made by Services and New OGI in the principal amount of $5,000,000 ("Term
Note"); and

         WHEREAS, on December 29, 1998, the Term Note was amended and restated
to include USC as an obligor on the Term Note (the "Amended Term Note"); and

         WHEREAS, on February 11, 2000, the Term Note was further amended and
restated (the "Second Amended Term Note"); and

         WHEREAS, on June 13, 2000, the Term Note was further amended and
restated (the "Third Amended Term Note"); and

         WHEREAS, Lender is the holder of a certain Revolving Note dated March
31, 1998 made by Services and New OGI in the principal amount of $5,000,000
("Revolving Note"); and

         WHEREAS, on December 29, 1998, the Revolving Note was amended and
restated to include USC as an obligor on the Revolving Note (the "Amended and
Restated Revolving Note"); and

         WHEREAS, on January 14, 1999, the Revolving Note was again amended and
restated to reflect an increase in principal amount to $7,000,000 (the "Second
Amended and Restated Revolving Note"); and

         WHEREAS, on June 29, 1999, the Revolving Note was again amended and
restated to reflect a decrease in the principal amount to $5,000,000 (the "Third
Amended Revolving Note"); and

         WHEREAS, on February 11, 2000, the Revolving Note was further amended
and restated (the "Forth Amended Revolving Note"); and

<PAGE>   2
         WHEREAS, on June 13, 2000, the Revolving Note was further amended and
restated (the "Fifth Amended Revolving Note"); and

         WHEREAS, Lender, Enterprises, Services and New OGI entered into a Loan
Agreement dated as of March 31, 1998 ((i) as amended by a First Amendment to
Loan Documents dated as of December 29, 1998 to which USC became a party, (ii)
as amended by a Second Amendment to Loan Documents dated as of January 14, 1999,
(iii) as amended by Third Amendment to Loan Documents dated as of June 30, 1999,
(iv) as amended by a Fourth Amendment to Loan Documents dated as of November 19,
1999, (v) as amended by the Fifth Amendment to Loan Documents dated as of
February 11, 2000, and (vi) as amended by the Sixth Amendment to Loan Documents
dated as of June 15, 2000) (the "Loan Agreement"); and

         WHEREAS, the Fifth Amended Revolving Note and the Third Amended Term
Note are secured as provided in the Loan Agreement and by such other documents
as have been executed to effectuate the terms of the Loan Agreement, which
documents include, but are not limited to a Security Agreement, Guaranty of
Enterprises, and a Pledge Agreement (all such documents collectively referred to
as the "Loan Documents"); and

         WHEREAS, the Borrower has requested that Lender extend the Final
Maturity Date of the Loan Documents (the "Extension"); and

         WHEREAS, Lender agrees to the Extension upon the condition that each
member of the Inmark Group execute this Amendment;

         NOW THEREFORE, for and in consideration of the premises (which are
deemed herein contained) and other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the parties agree as follows:

1.       RECITALS INCORPORATED.
         The Recitals set forth above are true and correct and are hereby
incorporated into this Amendment as if set forth at length herein.

2.       DEFINITIONS.
         Capitalized terms used in this Amendment shall have the same meanings
given them in the Loan Agreement, unless otherwise defined herein.

3.       PRINCIPAL AMOUNTS OUTSTANDING.

         The Borrower acknowledges that:

(a)      the outstanding principal balance due from the Borrower under the Third
         Amended Term Note is, as of June 23, 2000, equal to the sum of
         $1,710,000, together with unpaid interest; and

(b)      the outstanding principal balance due from the Borrower under the Fifth
         Amended Revolving Note is, as of June 23, 2000, equal to the sum of
         $5,000,000, together with unpaid interest.

The Borrower hereby represents, warrants and confirms that there are no set-off
rights, claims or causes of action of any nature whatsoever which the Borrower
has or may assert against the

                                      -2-
<PAGE>   3
Lender under the Third Amended Term Note, Fifth Amended Revolving Note or any of
the other Loan Documents.

4.       FINAL MATURITY DATE.
         The definition of "Final Maturity Date" set forth in Exhibit A to the
Loan Agreement, and as amended in the Fifth Amendment to Loan Documents dated as
of February 11, 2000, is hereby deleted in its entirety, and replaced with the
following: "Final Maturity Date" means July 8, 2001.

5.       MINIMUM EBITDA.
         Anything in the Loan Documents notwithstanding, Section 6.1of the Loan
Agreement is amended to replace the Minimum EBITDA requirement corresponding to
the following date (and only the following date) with the quarterly EBITDA
requirement set forth below, which requirement shall be measured on a quarterly
basis, not on a rolling four quarter basis:

<TABLE>
<CAPTION>
         Quarter Ended                                        Minimum EBITDA
<S>                                                           <C>
         June 30, 2001                                        $1,000,000
</TABLE>

6.       MAXIMUM SENIOR DEBT LEVERAGE RATIO.
         Anything in the Loan Documents notwithstanding, Section 6.2 of the Loan
Agreement is amended to replace the Maximum Senior Debt Leverage Ratio
requirement corresponding to the following date (and only the following date)
with the quarterly ratio requirement set forth below, which requirement shall be
measured on a quarterly basis, not on a rolling four quarter basis:

<TABLE>
<CAPTION>
         Quarter Ended                     Maximum Senior Debt Leverage Ratio
<S>                                        <C>
         June 30, 2001                     2.8:1
</TABLE>

7.       FIXED CHARGE COVERAGE RATIO.
         Anything in the Loan Documents notwithstanding, Section 6.3 of the Loan
Agreement is amended to replace the Fixed Charge Coverage Ratio requirement
corresponding to the following date (and only the following date) with the
quarterly ratio requirement set forth below, which requirement shall be measured
on a quarterly basis, not on a rolling four quarter basis:

<TABLE>
<CAPTION>
         Quarter Ended                             Fixed Charge Coverage Ratio
<S>                                                <C>
         June 30, 2001                             1.25:1
</TABLE>

8.       REPRESENTATION REGARDING EVENTS OF DEFAULT.
         The execution of this Amendment and the consummation of the transaction
contemplated in this Amendment is not, and shall not be deemed to constitute, a
waiver, forbearance or cure of any default arising prior or subsequent to the
date of this Amendment. The Borrower represents that there exists no Events of
Default. The Borrower agrees that no delay on the part of Lender in exercising
any power or right shall operate as a waiver or forbearance of any such power or
right or preclude the further exercise of any other power or right. The remedies
herein are cumulative and not exclusive of any remedies provided by law. Any
notice to or demand given under the

                                      -3-
<PAGE>   4
terms of this Amendment shall not entitle the Borrower to further notice or
demand under any other Loan Document.

9.       RELEASE OF LENDER.
         As additional consideration for the Extension set forth herein,
Borrower hereby remises, releases, waives and forever discharges Lender and its
predecessors, successors and assigns, its parents, subsidiaries, officers,
directors, members, shareholders, agents, employees, representatives, attorneys
and any affiliated companies, their parents, subsidiaries, officers, directors,
shareholders, agents, employees, representatives and attorneys (collectively,
the "Released Parties") from any and all claims, demands, damages, actions or
causes of action whatsoever, known or unknown, from the beginning of time
through the date of this Amendment, related to the Loan Documents or the
administration of any of the above.

10.      NO LEGAL RESTRAINT.
         The Borrower represents that no (i) litigation, investigation or other
proceeding of or before any Governmental Authority is pending or, to the best of
knowledge of each member of the Inmark Group, threatened against any member of
the Inmark Group or any of its properties or revenues that could have a Material
Adverse Effect or (ii) injunction, writ, restraining order or any order of any
nature has been issued by any Governmental Authority directing that the
transactions provided for in this Amendment not be consummated as therein
provided.

11.      CONDITION SUBSEQUENT.
         This Amendment shall become automatically void and of no force and
effect if on or prior to July 11, 2000 Lender shall not have received a
certificate from the Secretary or an Assistant Secretary of each member of the
Inmark Group, dated the Closing Date, certifying (as applicable) that (i)
attached to each such certificate is a true, complete and correct copy of the
resolutions of the Board of Directors of such member of the Inmark Group
authorizing among other things the execution, delivery and performance of this
Amendment, and (ii) such resolutions have not been amended, modified, revoked or
rescinded since the dates on which they were adopted, and (iii) the incumbency
and signature of each officer signing this Amendment and any other certificate
or other document to be delivered pursuant hereto (and another officer of such
member of the Inmark Group shall certify as to the incumbency of such Secretary
or Assistant Secretary).

12.      CONTINUED VALIDITY OF ORIGINAL LOAN DOCUMENTATION.
         Except as otherwise provided herein, the Loan Documents and all other
documents executed in connection therewith, shall continue unchanged in full
force and effect, in accordance with their respective terms, and the parties
hereto hereby expressly confirm and reaffirm all of their respective
liabilities, obligations, representations, warranties, duties and
responsibilities under and pursuant to said Loan Documents.

13.      AMENDMENT CONTROLS.
         In the event of a conflict between the terms and conditions of this
Amendment and the terms and conditions of any of the Loan Documents, the terms
and conditions of this Amendment shall control.

14.      INDEMNIFICATION.

                                      -4-
<PAGE>   5
         (a) The Borrower hereby indemnifies and agrees to protect, defend and
hold harmless the Lender, any entity which "controls" the Lender within the
meaning of Section 15 of the Securities Act of 1933, as amended, or is under
common control with the Lender, and any member, officer, director, official,
agent, employee or attorney of the Lender, and their respective heirs,
administrators, executors, successors and assigns (collectively, the
"Indemnified Parties"), from and against any and all losses, damages, expenses
or liabilities of any kind or nature and from any suits, claims or demands,
including reasonable attorneys' fees incurred defending such claim, suffered by
any of them and caused by, relating to, arising out of, resulting from, or in
any way connected with the Loan Documents, this Amendment or the transactions
contemplated therein or herein including, without limitation: (i) any untrue
statement of a material fact contained in information submitted to Lender by the
Borrower or the omission of any material fact necessary to be stated therein in
order to make such statement not misleading or incomplete; and (ii) the failure
of the Borrower to perform any obligations herein required to be performed by
the Borrower, except that the Borrower shall not be required to indemnify the
Lender for their gross negligence or willful misconduct. In case any action
shall be brought against Lender or any other Indemnified Party in respect to
which indemnity may be sought against the Borrower, Lender shall promptly notify
the Borrower and the Borrower shall assume the defense thereof, and the payment
of all costs and expenses. Lender may select and employ counsel, provided that
the Borrower shall pay all of such counsel's fees, expenses and disbursements
and the Borrower shall indemnify Lender for any loss associated with or
resulting from such representation. The failure of Lender to so notify the
Borrower shall not relieve the Borrower of any liability they may have under the
foregoing indemnification provisions or from any liability which they may
otherwise have to Lender or any of the other Indemnified Parties, except to the
extent such failure to notify results in unreasonable prejudice to the Borrower.
Lender shall not be liable for any settlement of any such action effected
without their written consent, but if settled with the Borrower's consent, or if
there be a final judgment for the claimant in any such action, the Borrower
agrees to indemnify and save harmless Lender from and against any loss or
liability by reason of such settlement or judgment.

         (b) The provisions of this Section shall survive the term of this
Amendment and the repayment or other satisfaction of the Notes.

15.      PAYMENT OF FEES AND EXPENSES.
         Borrower shall pay to Lender, simultaneously with the execution and
delivery of this Amendment, an extension fee of thirty-five thousand dollars
($35,000).

         Borrower shall pay for all reasonable costs and expenses, including
attorneys fees, incurred by Lender in connection with the negotiation,
preparation and execution of this Amendment.

16.      NO NOVATION.
         It is the intention of the parties hereto that this Amendment shall not
constitute a novation and shall in no way adversely affect or impair the lien
priority of any of the Loan Documents.

17.      SURVIVAL PROVISIONS.
         The covenants, representations and obligations contained in this
Amendment shall survive the execution of all transactions contemplated by this
Amendment, and this Amendment shall bind and benefit the parties hereto and
their respective heirs, executors, administrators, personal representatives,
successors and assigns.

                                      -5-
<PAGE>   6
18.      ENTIRE AGREEMENT.
(a) This Amendment and the Loan Documents contain all of the covenants,
representations, warranties and agreements between the parties with respect to
the subject matters contained herein, and supercedes all prior agreements and
understandings, both written and oral, between the parties with respect to the
subject matter hereof. The parties to this Amendment acknowledge that all the
terms of this Amendment were negotiated at arm's length and after adequate and
independent investigation on their respective parts and that this Amendment and
all documents executed in connection therewith were prepared and executed
without duress, undue influence or coercion of any kind exerted by any party
upon the other.

(b) Each party acknowledges and confirms that it has not relied
upon Lender or any officer, director or employee of the Lender, or upon the
advice of any but its own accountants or counsel, concerning any aspect of the
transactions contemplated by this Amendment including, without limitation, the
tax implications thereof and the representations herein made.

19.      FURTHER ASSURANCES.
         The parties hereto agree to execute all such further instruments and
take all such further action that may be reasonably required by any party to
fully effectuate the terms and provisions of this Amendment and the transaction
contemplated herein.

20.      NOTICE TO THE LENDER.
         Any notices or other communications required to be given to the Lender
under the Loan Documents shall be sent in the manner contemplated under the Loan
Documents, addressed as follows:

                           PNC Bank, National Association
                           2 Tower Center
                           East Brunswick, New Jersey  08816
                           Attention:  David Jensen
                                       Vice President
                           Facsimile:  732-220-3499

With a copy to:

                           McCarter & English, LLP
                           Four Gateway Center
                           100 Mulberry Street
                           Newark, New Jersey  07102
                           Attention:  Lisa Bonsall, Esq.
                           Facsimile:  973-624-7070

21.      PARTICIPATIONS.
         Lender expressly retains and reserves its rights to sell and assign its
interests under the Loan Documents and this Amendment and fully disclose its
files in connection with the Loan Documents, and/or any collateral pledged in
connection therewith (the "Collateral"), to potential purchasers of the Lender's
interests under the Loan Documents.

22.      NO MODIFICATION OF AGREEMENT EXCEPT IN WRITING.

                                      -6-
<PAGE>   7
         The within Amendment encompasses all the terms between the parties,
notwithstanding any verbal communications between the parties. No further terms
shall be deemed effective, unless in writing and executed by both parties.

23.      WAIVER OF JURY TRIAL.
         THE BORROWER AND LENDER HEREBY WAIVE ANY RIGHT TO REQUEST A TRIAL BY
JURY IN ANY LITIGATION WITH RESPECT TO ANY ASPECT OF THIS AMENDMENT OR THE LOAN
DOCUMENTS. THE BORROWER ACKNOWLEDGES THAT IT HAS HAD THE OPPORTUNITY TO CONSULT
WITH INDEPENDENT COUNSEL WITH RESPECT TO THIS WAIVER.

24.      GOVERNING LAW.
         This Amendment shall be construed and enforced in accordance with the
laws of New York without regard to principles of conflicts of law.

25.      EVENT OF DEFAULT.
         Failure to timely make any payment contemplated in this Amendment, to
comply with any financial covenant contemplated in this Amendment, or the breach
of any representation or warranty contained herein shall constitute an event of
default ("Event of Default") under the Loan Documents.

         The Borrower's breach of any other representation or warranty contained
in, or its failure to comply with any term or covenant of any of the Loan
Documents, and/or any other document executed in connection with the foregoing,
shall constitute an Event of Default.

         Upon the occurrence of an Event of Default, Lender shall be free to
pursue all of its legal and equitable rights and remedies including, but not
limited to, all of its remedies under the Loan Documents, this Amendment, any
documents executed in connection herewith, and any remedies that may otherwise
exist at law or in equity.

26.      CONSTRUCTION.
         The parties hereto agree that the terms and language of this Amendment
were the result of negotiations between the parties and, as a result, there
shall be no presumption that any ambiguities in this Amendment shall be resolved
against either party. Any controversy over the construction of this Amendment
shall be decided neutrally, in light of its conciliatory purposes, and without
regard to events of authorship or negotiation. All terms and words used in this
Amendment, regardless of the number and gender in which used, shall be deemed to
include any other number or gender as the context or use thereof may require. If
more than one person or entity is named as the Borrower, each such person or
entity shall be jointly and severally liable for the representations,
warranties, covenants and obligations of the Loan Documents and this Amendment.
The captions contained in this Amendment are used for convenience of reference
only and in no way define limit or describe the scope or intent of this
Amendment or any particular paragraph or section hereof or the proper
construction hereof.

27.      ADMISSIBILITY.
         The terms of this Amendment, when executed, shall be fully admissible
in any court of law. The parties hereto waive any objection that may be
interposed under any state or federal rules of evidence as to the admissibility
of this document.

28.      NO THIRD PARTY BENEFICIARIES.

                                      -7-
<PAGE>   8
         It is not the intent of the parties who are signatories to this
Amendment to grant any rights whatsoever to parties who are not signatories to
this Amendment and no provision of this Amendment should be construed to grant
any rights to any party who is not a signatory herein.

29.      COUNTERPARTS.
         This Amendment may be executed in several counterparts, each of which,
when executed and delivered, shall be deemed an original, and all of which
together shall constitute one Amendment.

30.      CLOSING DATE.
         The Closing Date shall be the last date by which each Party executes
this Amendment.

31.      ASSIGNMENT.
         This Amendment shall be binding upon and inure to the benefit of
Lender, the Inmark Group and their respective permitted heirs, successors and
assigns. The Borrower shall not assign this Amendment without the prior written
consent of Lender.

                    [signatures appear on the following page]

                                      -8-
<PAGE>   9
THE BORROWER DECLARES THAT EACH PARTY TO THIS AMENDMENT HAS RECEIVED, WITHOUT
CHARGE, A TRUE COPY OF THIS AMENDMENT.

IN WITNESS WHEREOF, the parties have executed this Amendment as of the Closing
Date,

                                COACTIVE MARKETING GROUP, INC.
                                (f/k/a Inmark Enterprises, Inc.)

Attest: /s/ Gloria Perivolaris  By:  /s/ Donald A. Bernard
                                Name/Title Donald A. Bernard, Exec. V.P. and CFO
                                Date:  6/23/00

                                U.S. CONCEPTS, INC.
                                (a Delaware corporation)

Attest: /s/ Gloria Perivolaris  By:  /s/ Donald A. Bernard
                                Name/Title Donald A. Bernard, Exec. V.P. and CFO
                                Date:  6/13/00

                                INMARK SERVICES, INC.

Attest: /s/ Gloria Perivolaris  By:  /s/ Donald A. Bernard
                                Name/Title Donald A. Bernard, Exec. V.P. and CFO
                                Date:  6/23/00

                                OPTIMUM GROUP, INC.

Attest: /s/ Gloria Perivolaris  By:  /s/ Donald A. Bernard
                                Name/Title Donald A. Bernard, Exec. V.P. and CFO
                                Date:  6/23/00

                                PNC BANK, N.A.

Attest:  /s/ Donald Irwin       By:  /s/ David Jensen
                                Name/Title  David Jensen, Vice Pres.
                                Date:  6/26/00

                                      -9-<PAGE>   1
                      SECOND AMENDMENT TO SUPPLY AGREEMENT

         THIS SECOND AMENDMENT ("Second Amendment") is entered into as of the
20th day of June, 2000 (the "Effective Date") by and between DUSA
PHARMACEUTICALS, INC. ("DUSA"), a corporation organized and existing under the
laws of the State of New Jersey, USA, whose principal offices are at 25 Upton
Drive, Wilmington, Massachusetts, 01887, U.S.A., and SOCHINAZ S.A. ("SOCHINAZ"),
a corporation registered under the laws of the Canton of Valais, Switzerland,
whose principal offices are at 22, rte du Simplon, CH-1895 Vionnaz, Switzerland.

         WHEREAS, DUSA and SOCHINAZ entered into a Supply Agreement, dated
December 24, 1993, which was amended pursuant to the First Amendment to Supply
Agreement, dated July 7, 1994 (collectively the "Agreement"), pursuant to which
SOCHINAZ sells to DUSA and DUSA purchases from SOCHINAZ, a porphyrin precursor
generally known as 5-aminolevulinic acid ("ALA") meeting certain specifications
(the "Product"); and

         WHEREAS, pursuant to the Agreement, SOCHINAZ is required to manufacture
the Product in accordance with the current Good Manufacturing Practices ("cGMP")
established by the United States Food and Drug Administration (the "FDA"); and

         WHEREAS, DUSA believes that in consideration of the parties agreement
to amend the terms and conditions of the Agreement for the purpose of providing
DUSA with an option to renew the Agreement after the expiration of the Term
specified in the Agreement and to correct certain typographical and clerical
errors contained within the Agreement, and it is in its best interests of both
parties to reimburse SOCHINAZ for a portion of the costs SOCHINAZ incurred to
bring its manufacturing facility into compliance with cGMP, under the terms of
this Second Amendment.

         NOW, THEREFORE, in consideration of the foregoing, and other good and
valuable consideration, the receipt and sufficiency of which the parties
acknowledge, the parties hereby agree as follows:

         1.       DUSA shall pay to SOCHINAZ an aggregate of $1.0 Million U.S.
Dollars, as follows:

                  (a)   $250,000 in cash, by wire transfer of immediately
                        available funds to Credit Suisse - CH - 1870  Monthey /
                        Account No.: 192649-42-780 / SWIFT CRESCHZZ18L; and

                  (b)   DUSA shall issue to SOCHINAZ that number of shares of
                        DUSA common stock, no par value, (hereinafter
                        referred to as the "Shares") having, as of the
                        Effective Date, a fair market value of $750,000, the
                        actual number of Shares and the terms and conditions
                        of such issuance to be set forth in a certain Stock
                        Subscription Agreement being entered into by the
                        parties contemporaneously with the signing of this
                        Second Amendment.

<PAGE>   2

         2.       Sections 2.3, 2.4 and 2.5 of the Agreement, which currently
begin "Notwithstanding Paragraph 2.2 above...", shall be amended to correctly
refer to Paragraph 2.1, as follows: "Notwithstanding Paragraph 2.1 above..."

         3.       Section 6.2 of the Agreement, which in relevant part
currently states " ... SOCHINAZ is unable to supply DUSA's requirement of
Products. Products hereunder in which case DUSA...", shall be amended, deleting
the repetition of the word Products, as follows: " ... SOCHINAZ is unable to
supply DUSA's requirement of Products hereunder in which case DUSA...".

         4.       Section 9.1 shall be amended to state as follows: "This
Agreement shall have an initial term of five (5) years from the date the
Product is first approved for any therapeutic use by the U.S. Food and Drug
Administration (i.e., December 3, 1999) unless sooner terminated in accordance
with Section 9.2 or 9.3 below. DUSA shall have an option to renew this
Agreement on the same terms and conditions for a period of three (3) additional
years, provided that DUSA notifies SOCHINAZ no later that June 3, 2003 of its
intention to renew this Agreement."

         5.       Except as expressly provided in this Amendment, the Agreement
shall remain unmodified and in full force and effect and is hereby ratified and
affirmed. The execution, delivery, and effectiveness of this Second Amendment
shall not, except as expressly provided herein, operate as a waiver of any
right, power, or remedy of DUSA or SOCHINAZ under the Agreement.

         IN WITNESS WHEREOF, the parties execute this Agreement.

SOCHINAZ S.A.                               DUSA PHARMACEUTICALS, INC.

By:   /s/ Christian A. Borgeaud             By:   /s/ D.Geoffrey Shulman, MD
      -------------------------             -----------------------------------
      Christian A. Borgeaud                 D. Geoffrey Shulman, MD, FRCPC
      Chief Executive Officer               President & Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00011-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00011-of-00352.parquet"}]]